Cargando…

“Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults”

INTRODUCTION: Age is an important prognostic factor in differentiated thyroid cancer (DTC). Our aim was to evaluate differences in clinicopathological features and treatment outcomes among children and adult patients with DTC. MATERIALS AND METHODS: We studied 27 children (below 18 years) with DTC t...

Descripción completa

Detalles Bibliográficos
Autores principales: AL-Qahtani, Khalid Hussain, Tunio, Mutahir A., Al Asiri, Mushabbab, Aljohani, Naji J., Bayoumi, Yasser, Riaz, Khalid, AlShakweer, Wafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636902/
https://www.ncbi.nlm.nih.gov/pubmed/26546329
http://dx.doi.org/10.1186/s40463-015-0102-6
_version_ 1782399725528416256
author AL-Qahtani, Khalid Hussain
Tunio, Mutahir A.
Al Asiri, Mushabbab
Aljohani, Naji J.
Bayoumi, Yasser
Riaz, Khalid
AlShakweer, Wafa
author_facet AL-Qahtani, Khalid Hussain
Tunio, Mutahir A.
Al Asiri, Mushabbab
Aljohani, Naji J.
Bayoumi, Yasser
Riaz, Khalid
AlShakweer, Wafa
author_sort AL-Qahtani, Khalid Hussain
collection PubMed
description INTRODUCTION: Age is an important prognostic factor in differentiated thyroid cancer (DTC). Our aim was to evaluate differences in clinicopathological features and treatment outcomes among children and adult patients with DTC. MATERIALS AND METHODS: We studied 27 children (below 18 years) with DTC treated during the period 2000–2012 and were compared with (a) 78 adults aged 19–25 years and (b) 52 adults aged 26–30 years treated during the same period in terms of their clinicopathological features and long term treatment outcomes. Locoregional recurrence (LRR), locoregional control (LRC), distant metastasis (DM), distant metastasis control (DMC), disease free survival (DFS) and overall survival (OS) rates were evaluated. RESULTS: Mean age of children was 13.5 years (range: 5–18), while mean age of adults was 24.6 years (range: 19–30). In children, female: male ratio was 2.85:1, and in adults female: male ratio was 7.1:1 (P = 0.041). No significant difference in tumor size was seen between the two groups (P = 0.653). According to American Thyroid Association (ATA) risk stratification classification, the children (85.2 %) were found to have at high risk as compared to adults P = 0.001. Post-thyroidectomy complications and RAI induced toxicities were observed more in children than adults (P = 0.043 and P = 0.041 respectively). LRR occurred in 6 (22.2 %), 9 (11.5 %) and 3 (5.8 %) in age groups of <18 years, 19–25 years and 26–30 years respectively (P = 0.032); while DM was seen in 10 (37.0 %), 9 (10.3 %) and 5 (9.6 %) in age groups of <18 years, 19–25 years and 26–30 years respectively (P = 0.002). Ten year DFS rates were 67.3 % in age group below 18 years, 82.4 % in age group of 19–25 years and 90.1 % in age group of 26–30 years (P = 0.021). CONCLUSION: At the time of diagnosis, children with DTC were found to have more aggressive clinicopathological characteristics. Comparatively lower LRC, DMC and DFS rates in children warrants further multi-institutional studies.
format Online
Article
Text
id pubmed-4636902
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46369022015-11-08 “Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults” AL-Qahtani, Khalid Hussain Tunio, Mutahir A. Al Asiri, Mushabbab Aljohani, Naji J. Bayoumi, Yasser Riaz, Khalid AlShakweer, Wafa J Otolaryngol Head Neck Surg Original Research Article INTRODUCTION: Age is an important prognostic factor in differentiated thyroid cancer (DTC). Our aim was to evaluate differences in clinicopathological features and treatment outcomes among children and adult patients with DTC. MATERIALS AND METHODS: We studied 27 children (below 18 years) with DTC treated during the period 2000–2012 and were compared with (a) 78 adults aged 19–25 years and (b) 52 adults aged 26–30 years treated during the same period in terms of their clinicopathological features and long term treatment outcomes. Locoregional recurrence (LRR), locoregional control (LRC), distant metastasis (DM), distant metastasis control (DMC), disease free survival (DFS) and overall survival (OS) rates were evaluated. RESULTS: Mean age of children was 13.5 years (range: 5–18), while mean age of adults was 24.6 years (range: 19–30). In children, female: male ratio was 2.85:1, and in adults female: male ratio was 7.1:1 (P = 0.041). No significant difference in tumor size was seen between the two groups (P = 0.653). According to American Thyroid Association (ATA) risk stratification classification, the children (85.2 %) were found to have at high risk as compared to adults P = 0.001. Post-thyroidectomy complications and RAI induced toxicities were observed more in children than adults (P = 0.043 and P = 0.041 respectively). LRR occurred in 6 (22.2 %), 9 (11.5 %) and 3 (5.8 %) in age groups of <18 years, 19–25 years and 26–30 years respectively (P = 0.032); while DM was seen in 10 (37.0 %), 9 (10.3 %) and 5 (9.6 %) in age groups of <18 years, 19–25 years and 26–30 years respectively (P = 0.002). Ten year DFS rates were 67.3 % in age group below 18 years, 82.4 % in age group of 19–25 years and 90.1 % in age group of 26–30 years (P = 0.021). CONCLUSION: At the time of diagnosis, children with DTC were found to have more aggressive clinicopathological characteristics. Comparatively lower LRC, DMC and DFS rates in children warrants further multi-institutional studies. BioMed Central 2015-11-06 /pmc/articles/PMC4636902/ /pubmed/26546329 http://dx.doi.org/10.1186/s40463-015-0102-6 Text en © AL-Qahtani et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research Article
AL-Qahtani, Khalid Hussain
Tunio, Mutahir A.
Al Asiri, Mushabbab
Aljohani, Naji J.
Bayoumi, Yasser
Riaz, Khalid
AlShakweer, Wafa
“Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults”
title “Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults”
title_full “Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults”
title_fullStr “Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults”
title_full_unstemmed “Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults”
title_short “Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults”
title_sort “clinicopathological features and treatment outcomes of differentiated thyroid cancer in saudi children and adults”
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636902/
https://www.ncbi.nlm.nih.gov/pubmed/26546329
http://dx.doi.org/10.1186/s40463-015-0102-6
work_keys_str_mv AT alqahtanikhalidhussain clinicopathologicalfeaturesandtreatmentoutcomesofdifferentiatedthyroidcancerinsaudichildrenandadults
AT tuniomutahira clinicopathologicalfeaturesandtreatmentoutcomesofdifferentiatedthyroidcancerinsaudichildrenandadults
AT alasirimushabbab clinicopathologicalfeaturesandtreatmentoutcomesofdifferentiatedthyroidcancerinsaudichildrenandadults
AT aljohaninajij clinicopathologicalfeaturesandtreatmentoutcomesofdifferentiatedthyroidcancerinsaudichildrenandadults
AT bayoumiyasser clinicopathologicalfeaturesandtreatmentoutcomesofdifferentiatedthyroidcancerinsaudichildrenandadults
AT riazkhalid clinicopathologicalfeaturesandtreatmentoutcomesofdifferentiatedthyroidcancerinsaudichildrenandadults
AT alshakweerwafa clinicopathologicalfeaturesandtreatmentoutcomesofdifferentiatedthyroidcancerinsaudichildrenandadults